Genetic Hypertrophic Cardiomyopathy

Genetic hypertrophic cardiomyopathy (HCM) is a heart condition caused by genetic mutations that results in the thickening of the wall of the heart. This thickening can affect the heart’s ability to pump blood effectively and can potentially cause serious medical problems including heart failure and sudden death. It is the most common genetic heart disorder and affects 1 in 500 people worldwide. HCM is typically diagnosed through physical examination, electrocardiograms, echocardiograms, and genetic testing. Treatment options vary depending on the severity of the condition and can include lifestyle modifications, medications, and surgical procedures. Early diagnosis and management of HCM is essential to reduce the risk of complications and to improve overall patient outcomes.